TABLE 3.
Factors | N = 203 | Univariate | Multivariate | |||
---|---|---|---|---|---|---|
5Y‐survival | P value | HR | 95% CI | P value | ||
Age (y) | ||||||
≥65 | 129 | 72.3% | .21 | |||
<65 | 74 | 74.5% | ||||
Gender | ||||||
Male | 157 | 73.6% | .62 | |||
Female | 46 | 72.1% | ||||
Hepatitis virus | ||||||
Nonvirus | 66 | 68.9% | .14 | |||
HCV antibody | 99 | 72.6% | ||||
HBV antigen | 38 | 81.2% | ||||
AAC (mm3) | ||||||
≥250 | 150 | 67.9% | <.01 | 2.51 | 1.24‐5.09 | .01 |
<250 | 53 | 88.2% | ||||
Total bilirubin (mg/dL) | ||||||
≥1.5 | 11 | 36.4% | <.01 | |||
<1.5 | 192 | 75.4% | ||||
ALT (IU/L) | ||||||
≥50 | 45 | 79.4% | .25 | |||
<50 | 158 | 71.3% | ||||
Albumin (mg/dL) | ||||||
≥4.0 | 121 | 81.4% | <.01 | 1.98 | 1.21–3.22 | <.01 |
<4.0 | 82 | 59.6% | ||||
PT (%) | ||||||
≥80 | 154 | 72.2% | .70 | |||
<80 | 49 | 76.3% | ||||
ICG‐R15 (%) | ||||||
≥10 | 130 | 68.6% | .04 | |||
<10 | 73 | 81.2% | ||||
Operation time (min) | ||||||
≥360 | 76 | 61.7% | <.01 | |||
<360 | 127 | 77.8% | ||||
Blood loss (mL) | ||||||
≥400 | 75 | 73.2% | <.01 | 1.64 | 1.01–2.67 | .04 |
<400 | 128 | 81.2% | ||||
DCP (mAU/mL) | ||||||
≥40 | 114 | 66.3% | .06 | |||
<40 | 89 | 81.8% | ||||
AFP (ng/mL) | ||||||
≥40 | 60 | 60.0% | .03 | 2.49 | 1.48–4.17 | <.01 |
<40 | 143 | 78.8% | ||||
Child–Pugh | ||||||
Class A | 190 | 73.6% | .06 | |||
Class B | 13 | 66.6% | ||||
Anatomical hepatectomy | ||||||
Yes | 57 | 82.5% | .08 | |||
No | 146 | 69.5% | ||||
Hepatectomy | ||||||
Minor hepatectomy | 175 | 77.8% | <.01 | |||
Major hepatectomy | 28 | 44.6% | ||||
Number of tumor | ||||||
≥2 | 64 | 53.6% | <.01 | 2.15 | 1.30–3.57 | <.01 |
<2 | 139 | 82.3% | ||||
Tumor size (mm) | ||||||
≥40 | 58 | 51.7% | <.01 | 1.92 | 1.17–3.15 | <.01 |
<40 | 145 | 82.1% | ||||
Poorly differentiated | ||||||
Yes | 20 | 56.3% | .02 | |||
No | 183 | 74.9% | ||||
Vascular invasion | ||||||
Yes | 39 | 50.2% | <.01 | |||
No | 164 | 78.1% | ||||
Serosal invasion | ||||||
Yes | 28 | 66.5% | .30 | |||
No | 175 | 74.2% |
Abbreviations: ACC, abdominal aortic calcification; AFP, a‐fetoprotein; ALT, alanine aminotransferase; DCP, des‐gamma‐carboxy protein; HCC, hepatocellular carcinoma; HCV, hepatitis virus type C; ICGR‐15, indocyanine green clearance test; PT, prothrombin time.